Repligen (RGEN) Total Liabilities (2010 - 2026)
Repligen's (RGEN) quarterly Total Liabilities came in at $838.1 million in Q2 2026, little changed year-over-year from $839.9 million in Q2 2025, and up 1.56% quarter-over-quarter from $825.3 million in Q1 2026.
Analysis
Repligen (RGEN) Total Liabilities (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Total Liabilities for 17 consecutive years, with $838.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Liabilities changed 0.21% year-over-year to $838.1 million in Q2 2026; TTM through Jun 2026 was $838.1 million, a 0.21% change from a year earlier, with the FY2025 full-year figure at $843.6 million, down 1.56% from the prior year.
- Total Liabilities was $838.1 million for Q2 2026 at Repligen, up from $825.3 million in the prior quarter.
- Over five years, Total Liabilities peaked at $888.1 million in Q1 2024 and troughed at $549.0 million in Q3 2023.
- A 5-year average of $757.6 million and a median of $831.7 million in 2026 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities jumped 66.37% in 2022 and retreated 12.5% in 2023, its largest moves.
- Over 5 years, Total Liabilities stood at $620.9 million in 2022, then surged by 39.53% to $866.3 million in 2023, then retreated by 1.08% to $856.9 million in 2024, then declined by 1.56% to $843.6 million in 2025, then decreased by 0.64% to $838.1 million in 2026.
- The last three Total Liabilities figures came in at $838.1 million (Q2 2026), $825.3 million (Q1 2026), and $843.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 60.49 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 39.78 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 6.60 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 3.81 Bn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 4.82 Bn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 478.51 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 3.08 Bn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 838.15 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 204.52 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 3.65 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 838.15 Mn |
| Mar 31, 2026 | 825.31 Mn |
| Dec 31, 2025 | 843.57 Mn |
| Sep 30, 2025 | 840.62 Mn |
| Jun 30, 2025 | 839.89 Mn |
| Mar 31, 2025 | 866.66 Mn |
| Dec 31, 2024 | 856.95 Mn |
| Sep 30, 2024 | 813.96 Mn |
| Jun 30, 2024 | 881.57 Mn |
| Mar 31, 2024 | 888.10 Mn |
| Dec 31, 2023 | 866.34 Mn |
| Sep 30, 2023 | 548.99 Mn |
| Jun 30, 2023 | 600.20 Mn |
| Mar 31, 2023 | 621.23 Mn |
| Dec 31, 2022 | 620.90 Mn |
| Sep 30, 2022 | 627.42 Mn |
| Jun 30, 2022 | 639.55 Mn |
| Mar 31, 2022 | 617.42 Mn |
| Dec 31, 2021 | 608.29 Mn |
| Sep 30, 2021 | 526.13 Mn |